Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors.
about
Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors.Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.
P2860
Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@en
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@nl
type
label
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@en
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@nl
prefLabel
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@en
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@nl
P2093
P356
P1476
Investigation of binding featu ...... between CYP2A6 and inhibitors.
@en
P2093
Chunzhi Ai
Guangbo Ge
Peipei Dong
Yonghua Wang
P2860
P304
P356
10.1002/JCC.21455
P577
2010-07-01T00:00:00Z